Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina.

Literature DB >> 34012160

Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina.

S Zimman¹, M J Cura¹, P C Lun², C M Echeverría³, L D Mazzuoccol¹.

Abstract

Mesh：

Year: 2020 PMID： 34012160 PMCID： PMC7567694 DOI： 10.1016/j.adengl.2020.10.010

Source DB: PubMed Journal: Actas Dermosifiliogr ISSN： 0001-7310

Keyword Cloud
References

× No keyword cloud information.

6 in total

1. Should patients stop their biologic treatment during the COVID-19 pandemic.

Authors: Arjun M Bashyam; Steven R Feldman
Journal: J Dermatolog Treat Date: 2020-03-19 Impact factor: 3.359

Review 2. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.

Authors: Alan Menter; Bruce E Strober; Daniel H Kaplan; Dario Kivelevitch; Elizabeth Farley Prater; Benjamin Stoff; April W Armstrong; Cody Connor; Kelly M Cordoro; Dawn M R Davis; Boni E Elewski; Joel M Gelfand; Kenneth B Gordon; Alice B Gottlieb; Arthur Kavanaugh; Matthew Kiselica; Neil J Korman; Daniela Kroshinsky; Mark Lebwohl; Craig L Leonardi; Jason Lichten; Henry W Lim; Nehal N Mehta; Amy S Paller; Sylvia L Parra; Arun L Pathy; Reena N Rupani; Michael Siegel; Emily B Wong; Jashin J Wu; Vidhya Hariharan; Craig A Elmets
Journal: J Am Acad Dermatol Date: 2019-02-13 Impact factor: 11.527

6. Telehealth: Helping your patients and practice survive and thrive during the COVID-19 crisis with rapid quality implementation.

Authors: Ivy Lee; Carrie Kovarik; Trilokraj Tejasvi; Michelle Pizarro; Jules B Lipoff
Journal: J Am Acad Dermatol Date: 2020-03-27 Impact factor: 11.527

6 in total

Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina.

1. Should patients stop their biologic treatment during the COVID-19 pandemic.

Review 2. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.

3. Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases.

4. Should biologics for psoriasis be interrupted in the era of COVID-19?

5. COVID-19 and immunomodulator/immunosuppressant use in dermatology.

6. Telehealth: Helping your patients and practice survive and thrive during the COVID-19 crisis with rapid quality implementation.